Home/ Supplements/ Vitamin C/ Restavin

Restavin

product on market Liquid Rejuvica Health Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin C, folic acid, and iron are supported by strong evidence for supporting cellular health and blood function. However, the overall evidence coverage for this specific formulation is very low at 0.4%. The product maintains a high safety score, though the proprietary blend lacks detailed transparency.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Restavin
Open Full PDF View on NIH DSLD →
Details

Label Data

1.23 mL
Serving Size
48
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin C
13 mg (14% DV)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
Iron
1.5 mg (8% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
Proprietary Blend
1.23 mL

Other Ingredients

Vegetable Glycerin purified Water Liquid Trace Minerals
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Suggested Use: As a dietary supplement take 1/4 teaspoon (1.23mL) 1-3 times a day or as needed. Take with a full glass of water.

Warnings & Precautions

Warning: Consult a qualified healthcare practitioner prior to using herbal products particularly if you are pregnant, nursing or on medications.

Discontinue two weeks before scheduled surgery.

Formulation Notes

Support for leg discomfort

Liquid herbal formula

Potent valerian extraction

Additional Information

Store in a cool, dry place with lid tightly closed. Do not expose to excessive heat.

Metadata

Product Details

DSLD Entry Date2020-12-26
Product TypeOther Combinations
FormLiquid
DSLD ID240938
Data Updated2026-04-11
Research

Research Evidence

371
Research Sources
54
Avg Quality
148
Meta Analysis
82
Systematic Review
71
Rct
62
Clinical Trial
2
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Other
1
Openfda Safety
A Vitamin C supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for the primary prevention of cardiovascular disease
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin C for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin C for preventing and treating pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Nutritional interventions for preventing and treating pressure ulcers
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Does Vitamin C Supplementation Provide a Protective Effect in Periodontal Health? A Systematic Review and Meta-Analysis
Meta Analysis International journal of molecular sciences 2024 PubMed DOI
A Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
Meta Analysis BMC medicine 2021 PubMed DOI
View all evidence for Vitamin C →
Compare

Similar Products

View all Vitamin C products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.